Cygnal Therapeutics
www.cygnaltx.comFounded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platform™, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.
Read more
Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platform™, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Founded
2017
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President of Finance
Email ****** @****.comPhone (***) ****-****Director , Assay Development / Hit Generation Science
Email ****** @****.comPhone (***) ****-****Senior Accounting Manager
Email ****** @****.comPhone (***) ****-****Laboratory Operations Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(10)
